ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), a stem cell-derived exosome-based drug delivery platform developer, is currently seeking new investors to enable the company to trade as a going concern following its
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), a stem cell-derived exosome-based drug delivery platform developer, is currently seeking new investors to enable the company to trade as a going concern following its






